For the past three years, Mr. Kiil has served as president of global orthopedics at Smith+Nephew, where he was responsible for the company’s reconstructive arthroplasty, robotics, trauma and extremities businesses.
Prior to Smith+Nephew, he was executive vice president and president of global commercial operations at NuVasive and also served as surgical head of Novartis’ Alcon eye care division for Europe, the Middle East, Africa, and Russia, where he led the commercial transformation of the surgical business across developed and emerging growth markets.
Additionally, over a 12-year period at Stryker, Mr. Kiil held several leadership roles, including vice president and general manager for Europe and general manager for Japan.
In his new role, he will be responsible for driving innovation and delivering therapies to global markets more effectively as well as cultivating a strong culture within the cranial and spinal technologies unit.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
